Balestrazzi A, Balestrazzi A, Menicacci F, Cartocci G, Menicacci F, Michieletto P, Balestrazzi E
From the Ophthalmology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
Ophthalmic Hospital, Rome, Italy.
Eye (Lond). 2017 Aug;31(8):1168-1175. doi: 10.1038/eye.2017.44. Epub 2017 Apr 7.
PurposeTo evaluate the refractive and visual results of one-stage laser-assisted in situ keratomileusis with femtosecond laser (Femto-LASIK) for the correction of residual ametropia after deep anterior lamellar keratoplasty (DALK).MethodsThis retrospective study included 13 eyes of 12 patients, who underwent corneal Femto-LASIK to correct refractive errors after DALK. IntraLase FS150 was used to create a lamellar flap and excimer laser ablation for refractive correction was performed using the Star S4 IR Excimer Laser in eight cases and the Technolas 217z Excimer Laser in Tissue Saving mode in five cases. Perioperative variables of interest included uncorrected (UDVA) and corrected (CDVA) distance visual acuities, manifest refraction and corneal topography.ResultsThe mean spherical equivalent preoperatively was -4.85±2.82 (range, -9.5 to 0 D). At the last visit the mean postoperative spherical equivalent (SE) was -0.44±0.67 D (P<0.05). The mean postoperative UDVA was 0.12±0.12 logMAR. There was a statistically significant increase in CDVA 6 months after Femto-LASIK (P<0.05). Intraoperative and postoperative complications did not develop in this series of eyes.ConclusionsCorrecting the preoperative manifest refractive error with Femto-LASIK led to a significant improvement in the UDVA and CDVA without surgical complications.
目的
评估飞秒激光一步法准分子原位角膜磨镶术(飞秒激光制瓣准分子原位角膜磨镶术)矫正深板层角膜移植术(DALK)后残余屈光不正的屈光和视觉效果。
方法
这项回顾性研究纳入了12例患者的13只眼,这些患者在DALK术后接受了角膜飞秒激光制瓣准分子原位角膜磨镶术以矫正屈光不正。8例使用IntraLase FS150制作角膜瓣,使用Star S4 IR准分子激光进行屈光矫正;5例使用Technolas 217z准分子激光在组织节省模式下进行屈光矫正。感兴趣的围手术期变量包括未矫正远视力(UDVA)、矫正远视力(CDVA)、显验光和角膜地形图。
结果
术前平均等效球镜度为-4.85±2.82(范围,-9.5至0 D)。在最后一次随访时,术后平均等效球镜度(SE)为-0.44±0.67 D(P<0.05)。术后平均UDVA为0.12±0.12 logMAR。飞秒激光制瓣准分子原位角膜磨镶术后6个月CDVA有统计学意义的提高(P<0.05)。这组眼中未发生术中及术后并发症。
结论
用飞秒激光制瓣准分子原位角膜磨镶术矫正术前显验光不正可显著改善UDVA和CDVA,且无手术并发症。